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ttps://doi.org/10.1016/j.ajpath.2017.11.007Fibroblasts persist within fibrotic scar tissue and exhibit considerable phenotypic and functional
plasticity. Herein, we hypothesized that scar-associated fibroblasts may be a source of stress-
induced inflammatory exacerbations and pain. To test this idea, we used a human model of
surgery-induced fibrosis, total knee arthroplasty (TKA). Using a combination of tissue protein
expression profiling and bioinformatics, we discovered that many months after TKA, the fibrotic
joint exists in a state of unresolved chronic inflammation. Moreover, the infrapatellar fat pad, a
soft tissue that becomes highly fibrotic in the post-TKA joint, expresses multiple inflammatory
mediators, including the monocyte chemoattractant, chemokine (C-C motif) ligand (CCL) 2, and
the innate immune trigger, IL-1a. Fibroblasts isolated from the post-TKA fibrotic infrapatellar fat
pad express the IL-1 receptor and on exposure to IL-1a polarize to a highly inflammatory state that
enables them to stimulate the recruitment of monocytes. Blockade of fibroblast CCL2 or its
transcriptional regulator NF-kB prevented IL-1aeinduced monocyte recruitment. Clinical in-
vestigations discovered that levels of patient-reported pain in the post-TKA joint correlated with
concentrations of CCL2 in the joint tissue, such that the chemokine is effectively a pain biomarker
in the TKA patient. We propose that an IL-1aeNF-kBeCCL2 signaling pathway, operating within
scar-associated fibroblasts, may be therapeutically manipulated for alleviating inflammation and
pain in fibrotic joints and other tissues. (Am J Pathol 2018, 188: 696e714; https://doi.org/
10.1016/j.ajpath.2017.11.007)Supported by the Medical Research Council grant MR/K001949/1,
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Department of HealthFibrosis is the excessive deposition of scar tissue arising
within a tissue or joint after injury or trauma.1 Adhesions are
fibrous bands that are generated after surgery; they form
physical connections between tissues that are not normally
directly connected, resulting in derangement and loss of
function of the affected tissue or joint.2 Fibrous adhesions
can also be associated with intermittent periods of acute
inflammation, debilitating pain, and progressive degenera-
tion of the affected tissue or joint.3 Therapeutic modulation
of these acute exacerbations is limited by our current poor
understanding of their underlying molecular triggers and
mediators.stigative Pathology. Published by Elsevier Inc.
Y license (http://creativecommons.org/licenses/by/4.0).
Table 1 Patient Demographics
Variable
Sex,
M:F ratio
Age in years,
median (range)
BMI,
median (range)
Time in months from
primary to revision TKA,
median (range)
Primary indication
for surgery
Primary TKA (n Z 29) 17:12 66 (44e81) 32 (22e47) NA Osteoarthritis (n Z 28),
rheumatoid disease (n Z 1)
Revision TKA (n Z 33) 16:17 71 (40e88) 33 (23e46) 106 (8e360) Osteolysis and loose
components (n Z 11),
clinical diagnosis of fibrosis with
loss of movement (n Z 11),
primary laxity pattern with functional
instability (n Z 8),
progression of osteoarthritis
(previous patellofemoral resurfacing)
(n Z 3)
F, female; M, male; BMI, body mass index; NA, not applicable; TKA, total knee arthroplasty.
Fibroblasts Drive Inflammation and PainThe cell type responsible for the deposition of fibrotic
extracellular matrix is the fibroblast.4,5 After tissue damage,
resident pericytes, fibroblasts, or epithelial cells trans-
differentiate to the fibroblast phenotype characterized by
their expression of a-smooth muscle actin and abundant
secretion of collagens.6 Resolution of wound healing is
associated with the clearance of fibroblasts, whereas the
maintenance and progression of fibrosis is associated with
fibroblast proliferation and survival.7 Fibroblasts exhibit
considerable phenotypic plasticity and may even reverse
transdifferention or alternatively adopt an inactivated state
characterized by reduced secretion of extracellular matrix
proteins and an extended lifespan of several weeks.8,9 An
often underappreciated feature of fibroblasts is their ability
to adopt an immune effector phenotype in response to
stimulation with IL-1a/b or tumor necrosis factor-a.10e13
We recently described how epithelial stress, via release of
IL-1a, triggers the polarization of lung fibroblasts toward a
proinflammatory phenotype characterized by their highly
abundant secretion of IL-6, IL-8, chemokine (C-C motif)
ligand (CCL) 2 (monocyte chemoattractant protein-1), and
granulocyte-macrophage colony-stimulating factor.14,15
Similar inflammatory cytokine release has also been
described in hepatic stellate cells,16 cardiac fibroblasts,17
dermal fibroblasts,18 and fibroblasts isolated from the
knee,19 suggesting the ability to adopt an immunomodula-
tory state may be a ubiquitous property of fibroblasts.
Herein, we hypothesized that fibroblasts persisting within
fibrotic microenvironments may be a source of stress-
induced inflammatory exacerbations and pain.
To test this hypothesis, we used a human model of surgery-
induced fibrosis, the post-surgical knee. Total knee arthro-
plasty (TKA) is a proven cost-effective treatment for painful
end-stage knee osteoarthritis, in which the articulating joint
surfaces are removed and replaced with new prosthetic-
bearing surfaces.20,21 After surgery, the TKA knee is char-
acterized by a fibrotic process, the persistence of fibroblasts
lasting months after surgery, and the deposition of vast
quantities of fibrotic extracellular matrix.22,23 Furthermore,The American Journal of Pathology - ajp.amjpathol.orgapproximately 20% of TKA patients report swelling and pain
of their joint that can be more severe than that experienced
before surgery.24,25 By acquiring synovial fluid and tissue
from patients undergoing primary TKA (nonfibrotic) and
patients undergoing revision TKA (fibrotic), we were able to
define the inflammatory profile of the fibrotic joint and a role
for IL-1 receptor (IL-1R1), expressing inflammatory fibro-
blasts. Using a combination of bioinformatics and in vitro
assays, we provide evidence that inflammatory fibroblasts
regulate monocyte recruitment to fibrotic tissues via the
release of CCL2 and demonstrate that CCL2 levels in the
post-TKA joint correlate with reported pain.
Materials and Methods
Ethics
This study was performed in accordance with approval from
the Newcastle and North Tyneside Local Regional Ethics
Committee, and informed written consent was obtained
from all patients (12/NE/0395). Samples used in this
research were obtained from the Newcastle Biomedicine
Biobank (Newcastle upon Tyne, UK; http://www.ncl.ac.uk/
nbb/collections).
Tissue Collection and Patient Stratification
All patients undergoing revision surgery for failed primary
TKA were included in the study during a 2-year period, with
infection being the only exclusion criterion. Synovial fluid,
infrapatellar fat pad, and synovial membrane (suprapatellar
pouch) were collected from patients undergoing either pri-
mary (n Z 29) or revision (n Z 33) TKA at the Freeman
Hospital (Newcastle upon Tyne, UK) (Table 1).
Revision TKA patients were stratified as those with
osteolysis and loose components (n Z 11), a clinical
diagnosis of fibrosis with loss of movement (n Z 11),
primary laxity pattern with functional instability (n Z 8, of
which n Z 6 had lost posterior cruciate ligamenterequired697
Paish et alrevision to a higher constraint prosthesis and n Z 2 had
midpoint laxity and the collateral ligaments were lax in full
extension and underwent revision to a higher constraint
implant), and progression of osteoarthritis (previous patel-
lofemoral resurfacing) (n Z 3). In the revision cohort, the
primary knee replacements were as follows: 16 PFC (Sigma,
St. Louis, MO), six Kinemax (Howmedica Osteonics Cor-
poration, Mahwah, NJ), two Triathlon (Stryker, Kalamazoo,
MI), one Genesis II (Smith and Nephew, London, UK), one
Oxford unicompartmental (Zimmer, Warsaw, IN), one
Vanguard (Biomet, Warsaw, IN), one AGC (Biomet), one
IB2 (Zimmer), one Noiles (DePuy, Raynham, MA), and
three primary patella-femoral resurfacing. Six revision pa-
tients with a total knee replacement in situ also had a
patella-femoral resurfacing.
For the purposes of our study, we used a definition of
primary joint fibrosis as previously described.22,26 In all
primary and revision TKA patients, local anesthetic was
administered intraoperatively under direct vision (to a
maximum dose of 100 mL of 0.2% ropivacaine). All pa-
tients were given routine postoperative analgesia, including
regular paracetamol and a patient-controlled analgesia de-
vice. In addition, patients with restricted range of motion
(fibrotic revisions) underwent continuous passive movement
for 48 to 72 hours postoperatively.
Routine practice in our unit includes excision of the
infrapatellar fat pad. All primary patients in the study had their
infrapatellar fat pad removed. In the revision cohort, 24 had
primary surgery performed in our unit and, therefore, had
their infrapatellar fat pad removed in the primary procedure.
The remaining nine revision patients had surgery elsewhere,
and we do not know whether the infrapatellar fat pad was
removed in their primary procedure. The infrapatellar fat pad
tissue resected in revision surgery was from an anatomically
matched site to the normal fat pad tissue found in the primary
knee and resected in primary replacement surgery.
Synovial fluid was collected by aspirating fluid from the knee
during surgery. The sample was sterile filtered (0.4 mm thick)
and stored at 80C. Representative tissue biopsy specimens
from infrapatellar fat pad and synovial membrane were fixed in
formalin and paraffin embedded. Serial tissue sections (5 mm
thick) were cut and processed for staining, as described later.
Tissue was homogenized in radioimmunoprecipitation assay
buffer supplemented with protease and phosphatase inhibitors
using a bead homogenizer (TissueLyserII; Qiagen, Hilden,
Germany). Homogenized samples were normalized to 1mg/mL
total protein (protein concentration measured using a bicincho-
ninic acid protein assay; Pierce, Waltham, MA), as per manu-
facturer’s instructions, and stored at 80C
Exclusion of Infection
Preoperative workup included C-reactive protein (all pa-
tients) and joint aspiration (7 of 33 revision patients). Joint
aspiration was performed only when the treating clinician
believed that infection needed to be excluded. C-reactive698protein was <30 in all revision patients, and all preoperative
joint aspiration samples were negative after extended culture.
Infection was definitively ruled out in all revision patients by
microbiological analysis of synovial fluid and of multiple
tissue samples taken at revision surgery. All revision patients
had negative extended culture of both intraoperative synovial
fluid and tissue samples. A minimum of three and a
maximum of six tissue samples were taken intraoperatively,
according to prosthetic joint infection guidelines.27 As is
standard practice, all orthopedic theater samples underwent
extended enrichment culture for 10 days. However, a role for
organisms, such as Propionibacterium acnes, that are chal-
lenging to culture, and may be an underrecognized cause of
knee prosthetic joint infection, cannot be ruled out.28,29
Histological Analysis of Tissue Samples
Formal histology reports were available for 9 of 33 revision
patients. All reports state that dense, hypocellular, heavily
collagenizedfibrous tissue foreign body giant cells containing
small transparent, strongly birefringent foreign particles were
identified. The appearances are those of extensive fibrosis
together with a focal giant cell reaction to foreign material, a
reaction to polyethylene debris from the prosthetic joint
implant. There was no evidence of infection reported in any
cases.
Immunohistochemistry
Tissue sections (5 mm thick) were deparaffinized in xylene,
rehydrated in graded alcohol, and incubated in 0.6%
hydrogen peroxide/methanol for 15 minutes. Antigen
retrieval was performed using 20 mg/mL Proteinase K
(Sigma) in phosphate-buffered saline (PBS) at 37C for 30
minutes. Blocking was performed using Avidin/Biotin Block
(Vector Laboratories, Burlingame, CA), followed by porcine
serum. Primary antibody incubationwas performed overnight
at 4C using rabbit polyclonal primary antibody against IL-
1R1 (Ab106278; Abcam, Cambridge, UK). Slides were
washed with PBS and incubated with anti-rabbit biotinylated
antibody (0.51 mg/L; Dako, Santa Clara, CA) in 1% porcine
serum for 1 hour at room temperature. ABC tertiary (Vector
Laboratories) was then applied to slides for 45 minutes at
room temperature before application of 3,30-dia-
minobenzidine mix (Vector Laboratories) for 5 minutes,
followed by counterstaining with Mayer’s hematoxoylin
(Sigma). Slides were dehydrated in graded ethanol and
Clearene (Leica Biosystems, Wetzlar, Germany) before
mounting using Pertex (CellPath Ltd., Newtown Powys,
UK). Images were acquired using a Nikon Eclipse Upright
Microscope (Nikon Instruments Europe BV, Amsterdam, the
Netherlands). For CD68 image quantification, the mean
number of positive cells in 10 randomly selected high-
powered fields (20 magnification) was calculated using
Nikon NIS elements image analysis software version 4.0
(Nikon Instruments Europe BV).ajp.amjpathol.org - The American Journal of Pathology
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Tissue sections (5 mm thick) were deparaffinized in xylene
and rehydrated in graded alcohol. Antigen retrieval was
performed with proteinase K (20 mg/mL in PBS) for 30
minutes at 37C. Samples were blocked with 5% bovine
serum albumin/PBS and incubated overnight at 4C with
primary antibodies diluted in 5% bovine serum albumin/
PBS [IL-1R1, ab106278 (Abcam, Cambridge UK); IL-6,
AF-206 at 10 mg/mL (R&D Systems, Minneapolis, MN);
vimentin, M7020 at 62 mg/mL (Dako)]. Slides were
washed with PBS-Tween (0.05%) and incubated with
anti-rabbit tetrarhodamine isothiocyanate (T6778; Sigma-
Aldrich) and anti-mouse fluorescein isothiocyanate
(F2012; Sigma-Aldrich) diluted in 5% bovine serum al-
bumin/PBS for 1 hour at room temperature. Slides were
washed with PBS-Tween and mounted using mounting
medium with DAPI (H1200; Vector Laboratories). Images
were acquired on a Nikon A1R point scanning confocal
microscope.
Multiarray Protein Assays
Synovial fluid (primary, n Z 21; revision, n Z 24) and
tissue homogenates from infrapatellar fat pad (primary,
n Z 28 patients; revision, n Z 32 patients) and synovial
membrane (primary, n Z 29 patients; revision, n Z 32
patients) were assessed for expression of 39 protein
markers using a human V-Plex electrochemiluminescence
detection kit (K15209D; MesoScaleDiscovery, Rockville,
MD), as per manufacturer’s instructions. Analysis of re-
sults was performed using the MSD Discovery Workbench
software version 4.0 (MesoScaleDiscovery, Rockville,
MD).
Network Reconstruction
To identify potentially important intracellular signaling
pathways/processes likely occurring in the revision TKA
knee, we constructed a network using protein-protein
interactions from InnateDB (http://www.innatedb.com).
The differentially expressed markers and log(fold changes)
were uploaded to the web server NetworkAnalyst (http://
www.networkanalyst.ca),30 and the network was built with
direct interactions only from the innate DB interactome.31
The resulting network contains 730 nodes and 921 edges
and was visualized with Cytoscape.32 Statistics, such as
degree (number of connections of a given node) and
betweenness centrality (the number of paths between other
nodes passing through a given node), were calculated.
Modules (highly connected subnetworks) were found by a
method based on the spreading rate of a random walk on
the network. Significant gene ontology terms were
identified using overrepresentation of the proteins in the
network, or modules of the network, among gene sets
annotated with these terms.The American Journal of Pathology - ajp.amjpathol.orgFibroblast Isolation
Infrapatellar fat pad isolated from patients undergoing primary
and revision TKAwas homogenized and digested in 10 mL of
supplement-free medium [Dulbecco’s modified Eagle’s
medium (DMEM);D5671; Sigma] containing 100 units/mLof
collagenase (C6885; Sigma) for 60 minutes. Digested tissue
was passed through a 100-mm filter, and the collagenase was
neutralizedwith completemedium (DMEMplus 10% fetal calf
serum, 100 mg/mL streptomycin, 100 U/mL penicillin, and 1%
L-glutamate). Cells were pelleted and resuspended in complete
medium before transferring into T-75 flasks. Cells were
cultured at 37C and 5% CO2 until >90% confluent. Cells
were cryopreserved at passage number (P)0 or passaged and
cryopreserved at P1. Mesenchymal phenotype was confirmed,
as previously described.19 Fibroblasts were reanimated and
used between P2 and P5 for all experiments in this study.
Cell Treatments
Fibroblasts isolated from the infrapatellar fat pad of patients
undergoing primary (nZ6patients) or revision (nZ6patients)
TKAwere serum starved for 24 hours before treatment with 0%
fetal bovine serum (FBS) DMEM (control), 0% FBS
DMEM þ IL-1a (500 pg/mL), or 0% FBS DMEM þ trans-
forming growth factor (TGF)-b1 (3 ng/mL) for 24 hours. In
some experiments, fibroblasts were pretreated with inhibitors
[SP600125, SD1008, FR180204, SB203580, (5Z)-7-
oxozeaenol, IL-1 receptor associated kinase 1/4 inhibitor 1 (all
fromTocris,Minneapolis,MN) or IkBkinase (IKK)-2 inhibitor
VIII (MerckMillipore, Billerica, MA)] for 1 hour before treat-
ment with inhibitorsþ IL-1a (500 pg/mL). After 24 hours, the
medium was collected, spun at 800  g to clear, and stored at
80C for analysis or use in transwell migration assays.
Enzyme-Linked Immunosorbent Assay
IL-6, IL-8, and CCL2 protein levels in media samples from
fibroblasts were quantified by ELISA (R&D Systems), as per
manufacturer’s instructions.
Lactate Dehydrogenase Assay
Lactate dehydrogenase levels in media collected from
fibroblasts were quantified using a Pierce LDH Cytotoxicity
Assay Kit (Thermo Scientific, Waltham, MA), as per
manufacturer’s protocol.
THP-1 Cell
THP-1 cells are an acute monocytic leukemia human cell
line and were purchased from ATCC (TIB-202; ATCC,
Manassas, VA). Cells were cultured in RPMI-1640 media
(R0883; Sigma) supplemented with 10% FBS, 1% L-gluta-
mine, 100 U/mL penicillin, and 100 mg/mL streptomycin.
Cells were maintained at approximately 0.5  106 cells/mL,699
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700and medium was changed twice weekly. THP-1 cells were
used to provide a uniform monocyte population and ensure
the only experimental variable in transwell migration assays
was the composition of the conditioned media.
Transwell Migration Assay
Media from fibroblasts treatedwith 0%FBSDMEM (control),
0% FBS DMEM þ IL-1a (500 pg/mL), 0% FBS
DMEM þ TGF-b1 (3 ng/mL), or fibroblasts pretreated with
inhibitors before treatment with 0% FBS DMEM þ IL-1a
were placed directly into the bottom of a 24-well plate. Re-
combinant CCL2 (100 pg/mL) in 0%FBSDMEMwas used as
a positive control, and 0%FBSDMEMwas used as a negative
control. THP-1 cells (50,000 in 100 mL 0%FBSDMEM)were
added to a 6.5-mm, 5-mm pore transwell insert (Costar Corn-
ing, Corning, NY), and the insert was added to the 24-well
plate. After 18 hours, migrated cells were imaged using a
Nikon D5000 camera and quantified using ImageJ software
version 1.41 (NIH, Bethesda,MD; http://imagej.nih.gov/ij). In
some experiments, medium from fibroblasts treated with 0%
FBS DMEM þ IL-1a (500 pg/mL) was pretreated with
neutralizing antibodies against CCL2 (4 mg/mL; AF-479;
R&D Systems) and IL-6 (200 mg/mL; Ab6672; Abcam) for
1 hour before adding to the 24-well plate.
Clustering and Stratification
In the clustering analysis, protein expression values were
transformed according to log10(intensity þ 2*d), where d isFigure 1 Synovial fluid and tissues isolated from patients undergoing
revision total knee arthroplasty (TKA) are characterized by dramatic tissue
remodeling and chronic inflammation. A: Representative images of Masson
trichrome and IL-1R1 (green [fluorescein isothiocyanate (FITC)])/vimentin
(red [tetrarhodamine isothiocyanate (TRITC)]) stained infrapatellar fat pad
from patients undergoing primary TKA and patients undergoing revision
TKA. There is a significant increase in collagen and IL-1R1 expression in
revision TKA tissue compared with primary TKA tissue, and IL-1R1 is pre-
dominantly expressed on elongated bipolar mesenchymal cells in revision
TKA tissue. Images acquired on a Nikon inverted microscope and a Nikon
A1R point scanning confocal microscope, respectively. B: Venn diagram
demonstrating change in protein expression in synovial fluid, infrapatellar
fat pad, and synovial membrane isolated from patients undergoing revision
TKA compared with patients undergoing primary TKA. Protein expression
was quantified using human V-Plex electrochemiluminescence detection
kits from MesoScaleDiscovery. Markers in black text are significantly
elevated in revision TKA, markers in blue text are not significantly different
or undetectable, and markers in red text are significantly decreased in
revision TKA. Significance was taken as P < 0.05. C: Representative images
of vimentin [green (FITC)]e and IL-6 [red (TRITC)]estained infrapatellar
fat pad from patients undergoing revision TKA. There are a significant
number of vimentin and IL-6 dual-positive fibroblasts in post-TKA infra-
patellar fat pad. Images acquired on a Nikon A1R point scanning confocal
microscope. Original magnification, 20 (A and C); 40 (inset). CRP, C-
reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase
1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM,
intercellular adhesion molecule; IFN, interferon; IP-10, interferon gamma-
induced protein 10; PIGF, placental growth factor; SAA, serum amyloid A;
Tie, tyrosine kinase; TNF, tumor necrosis factor; VCAM, vascular cell
adhesion molecule; VEGF, vascular endothelial growth factor.
ajp.amjpathol.org - The American Journal of Pathology
Table 2 Synovial Fluid: Primary TKA versus Revision TKA
Marker
Primary TKA Revision TKA Revision versus Primary TKA
Median, pg/mL Range, pg/mL Median, pg/mL Range, pg/mL Fold change P value
Significantly increased
IL-8 35 0e655 898 62e36,728 25.49 <0.0001
CCL2 395 67e857 3744 318e23,297 9.48 <0.0001
CCL3 13 0e51 102 15e1257 7.93 <0.0001
IL-10 0.16 0e11.2 0.92 0e8.3 5.58 <0.0001
Flt-1 84 36e288 448 33e13,621 5.35 <0.0001
IL-5 0.23 0e2.1 1.05 0e19.4 4.56 <0.001
GM-CSF 0.19 0e4.5 0.71 0e4.0 3.71 <0.01
CCL13 15.0 9e415 54.8 14e1320 3.67 <0.0001
IP-10 256 130e9980 873 196e5562 3.41 <0.001
CCL4 60 27e195 200 36e1358 3.33 <0.0001
TNF-a 1.16 0.5e5.9 3.81 0.8e28.1 3.30 <0.0001
IL-16 331 107e5551 1022 180e7667 3.09 <0.0001
VEGF-C 184 74e509 534 83e1542 2.90 <0.0001
VEGF 379 91e948 1080 133e5555 2.85 <0.0001
CCL22 343 138e1087 954 174e4997 2.78 <0.0001
CCL17 28.0 11e337 71.7 14e384 2.56 <0.001
IL-23p40 42.8 6e652 90.2 11e403 2.11 <0.01
TNF-b 0.28 0e2.1 0.59 0e9.5 2.08 <0.001
CCL11 27.3 15e94 56.0 23e206 2.05 <0.001
IL-15 15.6 3e25 27.9 9e104 1.79 <0.0001
ICAM-1 66,071 25,024e265,365 101,434 31,383e458,122 1.54 <0.05
VCAM-1 100,705 31,963e167,370 128,900 70,772e210,136 1.28 <0.05
CCL26 0.0 0e36 13.3 0e107 NA <0.0001
IL-1b 0.00 0e1.3 0.10 0e47.1 NA <0.001
IL-1a 0.00 0e1.4 0.28 0e22.9 NA <0.01
IL-2 0.00 0e0.4 0.17 0e3.2 NA <0.05
Not significantly different
IL-17 1.87 0e47 4.28 1e49 2.29 0.23
IL-6 39.1 0e921 67.3 0e2236 1.72 0.18
IL-4 0.20 0e2.0 0.24 0e7.6 1.20 0.64
VEGF-D 352 137e593 411 185e1215 1.17 0.16
PlGF 497 159e5463 576 179e1777 1.16 0.67
Tie-2 1797 967e3547 1951 745e4970 1.09 0.95
CRP 875,587 11,385e1,421,021 902,869 25,449e1,865,959 1.03 0.72
IFN-g 2.54 0e105 2.53 0e55 1.00 0.88
SAA 205,119 43,141e851,868 198,230 57,469e1,072,174 0.97 0.81
IL-7 8.49 0.7e16.5 7.30 2.5e13.6 0.86 0.29
FGF2 35.2 3e512 21.6 3e495 0.61 0.25
IL-12p70 0.00 0e1.1 0.00 0e7.5 NA 0.11
IL-13 0.00 0e3.9 0.00 0e16.5 NA 0.09
CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM, inter-
cellular adhesionmolecule; IFN, interferon; IP-10, interferongamma-induced protein 10; NA, not applicable; PIGF, placental growth factor; SAA, serumamyloid A; Tie,
tyrosine kinase; TKA, total knee arthroplasty; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor.
Fibroblasts Drive Inflammation and Painthe smallest nonzero measured value. The measured
markers were then sorted by fold change between primary
and revision, and the top n values were used for clustering,
where n was chosen so that (n þ 1) is the first not signifi-
cantly DE between the two groups or where this would lead
to few proteins, n Z 10. The distance measure between
marker sets was the euclidean distance between the log-
transformed expression, and Ward’s method was used for
hierarchical clustering. Heat maps were generated with the
ComplexHeatmap package in R version 3.2.3 (The RThe American Journal of Pathology - ajp.amjpathol.orgFoundation for Statistical Computing, Vienna, Austria). For
display, each row is Z transformed to equalize differences in
overall expression. Principal component analysis was per-
formed using the base R function princomp and all markers.
Stratification with a Reduced Set of Markers
A reduced set of markers was selected with the R package
glmnet (http://www.jstatsoft.org/v33/i01).33 The binomial
family was used for the generalized linear model, with701
Table 3 Infrapatellar Fat Pad: Primary TKA versus Revision TKA
Marker
Primary TKA Revision TKA Revision versus Primary TKA
Median, pg/mL Range, pg/mL Median, pg/mL Range, pg/mL Fold change P value
Significantly increased
IL-8 6 0e117 225 0e2952 40.80 <0.0001
CCL4 2.8 0e12 26.0 0e522 9.25 <0.0001
CCL2 18 7e54 142 9e1491 8.03 <0.0001
IL-13 0.16 0e2.2 1.15 0e4.0 7.18 <0.01
IP-10 7.4 2e165 53.2 2e786 7.16 <0.0001
IL-6 0.24 0e1.9 1.25 0e8.5 5.15 <0.01
CCL22 41 12e125 154 21e3827 3.76 <0.0001
IL-1b 0.07 0e0.3 0.23 0e7.6 3.19 <0.001
CCL17 1.20 0e11 3.51 1e27 2.91 <0.0001
VEGF 22.5 0e83 61.5 8e1616 2.74 <0.0001
IL-15 1.47 0e8 3.09 0e21 2.10 <0.01
IL-16 233 112e890 459 0e1430 1.97 <0.01
PlGF 17.6 1e107 32.7 6e128 1.86 <0.05
CCL11 6.8 0e28 12.6 0e43 1.85 <0.01
ICAM-1 22,148 11,699e41,389 39,918 13,665e88,209 1.80 <0.001
SAA 33,446 19,242e82,008 51,401 21,488e239,797 1.54 <0.01
IL-23p40 0 0e4.3 1.35 0e18.2 NA <0.0001
IL-1a 0 0e0.6 0.49 0e3.7 NA <0.0001
IL-2 0 0e1.3 0.00 0e0.2 NA <0.05
IL-5 0 0e0.6 0.26 0e2.0 NA <0.001
CCL3 0 0e18 70.3 0e755 NA <0.0001
TNF-a 0 0e0 0.00 0e1.4 NA <0.01
Not significantly different
Flt-1 932 57e3910 1436 471e4431 1.54 0.06
VCAM-1 3748 1647e19,192 4964 1134e82,268 1.32 0.09
CRP 87,863 45,144e419,932 111,126 42,185e298,708 1.26 0.33
CCL26 7.46 0e55 7.92 0e288 1.06 0.90
CCL13 66.5 31e335 68.9 8e565 1.04 0.94
IL-4 0.05 0e0.2 0.05 0e0.2 0.95 0.28
GM-CSF 0 0e0.4 0 0e0.8 NA 0.09
IFN-g 0 0e0 0 0e0 NA >0.99
IL-10 0 0e0.1 0 0e0.3 NA >0.99
IL-12p70 0 0e0.5 0 0e0.1 NA 0.62
IL-17A 0 0e7.1 0 0e4.2 NA 0.36
IL-7 0 0e0.6 0 0e1.3 NA 0.09
TNF-b 0 0e0 0 0e1.1 NA 0.49
VEGF-C 0 0e26 0 0e36.6 NA 0.51
Significantly reduced
Tie-2 2849 149e4208 1712 125e4280 0.60 <0.001
FGF2 9734 258e17,546 3141 408e11,371 0.32 <0.0001
VEGF-D 76.7 0e237 24.3 0e193 0.32 <0.0001
CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM, inter-
cellular adhesionmolecule; IFN, interferon; IP-10, interferon gamma-inducedprotein 10;NA, not applicable; PIGF, placental growth factor; SAA, serumamyloidA; Tie,
tyrosine kinase; TKA, total knee arthroplasty; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor.
Paish et al10-fold cross validation to prevent overfitting. Data were
weighted so that each class (primary or revision) had equal
weight, despite different numbers of observations. In using
the single marker CCL2 alone to classify primary/revision
TKA patients, the model was fitted using the base R glm
function and the receiver operating characteristic curve
produced with the R package pROC.34 The median and CIs
on the area under the curve were calculated with the ci.auc
function.702Statistical Analysis
Markers in synovial fluid, synovial membrane, and
infrapatellar fat pat were grouped into those significantly
elevated, those significantly decreased, and those not
significantly different or undetectable in patients under-
going primary and revision TKA. Data are presented as a
Venn diagram, graphically as change in median expres-
sion levels, as box-and-whiskers plots for individualajp.amjpathol.org - The American Journal of Pathology
Table 4 Synovial Membrane: Primary TKA versus Revision TKA
Marker
Primary TKA Revision TKA Revision versus Primary TKA
Median, pg/mL Range, pg/mL Median, pg/mL Range, pg/mL Fold change P value
Significantly increased
IL-8 2 0e97 135 0e3042 84.50 <0.0001
CCL3 4.4 0e24 51.7 0e750 11.74 <0.0001
CCL4 6.0 0e65 33.0 0e380 5.53 <0.01
IP-10 13.3 3e1183 44.7 3e2507 3.37 <0.01
CCL2 36 9e191 109 8e720 3.03 <0.001
CCL22 45.0 10e145 88.7 26e1389 1.97 <0.0001
CCL17 0.99 0e58 1.68 0e19 1.69 <0.05
IL-23p40 0 0e7.1 1.08 0e10.8 NA <0.001
IL-13 0 0e3.5 0.98 0e5.1 NA <0.01
TNF-a 0 0e1.4 0.00 0e3.3 NA <0.05
Not significantly different
IL-1a 0.20 0e30 1.00 0e7 4.98 0.08
IL-6 0.17 0e4.8 0.72 0e12.6 4.28 0.05
IL-15 2.65 0e23) 4.51 0e18 1.71 0.25
IL-1b 0.11 0e0.3 0.17 0e14.1 1.54 0.09
VCAM-1 3799 1420e25,228 5163 2311e45,561 1.36 0.09
VEGF 10.3 0e46 13.8 0e362 1.33 0.94
IL-16 382 147e1743 493 135e3003 1.29 0.21
ICAM-1 33,978 15,606e115,625 36,721 17,683e95,444 1.08 0.25
SAA 41,586 22,888e84,910 43,694 21,989e159,994 1.05 0.21
PlGF 39.4 11e353 39.8 11e116 1.01 0.81
CCL11 6.61 0e34 6.53 0e41 0.99 0.36
CCL13 75.0 17e1199 70.7 6e609 0.94 0.80
Flt-1 1727 646e7201 1466 526e5691 0.85 0.32
IL-4 0.04 0e0.1 0.03 0e0.2 0.81 0.90
GM-CSF 0 0e1.4 0 0e1.1 NA >0.99
IFN-g 0 0e0.2 0 0e1.0 NA >0.99
IL-10 0 0e0 0 0e0.2 NA 0.24
IL-12p70 0 0e0.1 0 0e0.5 NA 0.24
IL-17A 0 0e7.7 0 0e4.3 NA 0.81
IL-2 0 0e0.4 0 0e0.4 NA 0.45
IL-5 0 0e2.2 0.36 0e1.5 NA 0.07
IL-7 0 0e0.9 0 0e1.9 NA 0.09
TNF-b 0 0e1.7 0 0e1.7 NA 0.64
VEGF-C 0 0e114 0 0e30 NA 0.60
Significantly reduced
Tie-2 3364 2006e4518 2322 138e5181 0.69 <0.001
CCL26 14.4 4e104 8.7 0e55 0.61 <0.01
CRP 255,593 46,461e1,128,993 121,677 42,048e355,751 0.48 <0.01
FGF2 8779 3453e15,081 3781 679e13,018 0.43 <0.0001
VEGF-D 66.5 8e390 22.7 0e249 0.34 <0.05
CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM,
intercellular adhesion molecule; IFN, interferon; IP-10, interferon gamma-induced protein 10; NA, not applicable; PIGF, placental growth factor; SAA, serum
amyloid A; Tie, tyrosine kinase; TKA, total knee arthroplasty; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial
growth factor.
Fibroblasts Drive Inflammation and Painmarkers, and in tabular form. Significance was calculated
using U-test. Correlations between IL-1a levels and
CCL2, IL-6, and IL-8 levels were tested using linear
regression. In vitro data are presented as means  SEM.
Differences between treatment groups were analyzed
using paired t-test (Graphpad Prism 6; GraphPad Soft-
ware Inc., La Jolla, CA). Significance was set at
P < 0.05.The American Journal of Pathology - ajp.amjpathol.orgResults
Chronic Inflammation Is a Common Feature of the
Postsurgical Joint
The post-TKA joint is associated with the persistence of fi-
broblasts and extensive fibrotic remodeling of the replacement
joint (Figure 1A).22,35 To determine the degree to which TKA703
Figure 2 Markers of inflammation are elevated in patients undergoing revision total knee arthroplasty (TKA). Fold change in protein expression in synovial
fluid (A), infrapatellar fat pad (B), and synovial membrane (C) isolated from patients undergoing revision TKA compared with patients undergoing primary
TKA. Fold change was calculated using median protein expression. Significance was calculated using U-test. *P < 0.05, **P < 0.01, ***P < 0.001, and
****P < 0.0001 primary versus revision patients. CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-
macrophage colony-stimulating factor; ICAM, intercellular adhesion molecule; IFN, interferon; IP-10, interferon gamma-induced protein 10; PIGF, placental
growth factor; SAA, serum amyloid A; Tie, tyrosine kinase; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial
growth factor.
Paish et alis associated with inflammation, synovial fluid, synovial
membrane, and infrapatellar fat pad were collected from pa-
tients undergoing primary or revision surgery and the expres-
sion of 39 soluble inflammatory proteins was profiled at each
anatomical location. When comparing protein expression be-
tween pre- and post-TKA samples, it was discovered that all
three anatomical locations in the fibrotic joint display an
enhanced proinflammatory state (Tables 2, 3, and 4, Figure 2,704and Supplemental Figures S1, S2, and S3). Synovial fluid was
the most dramatically affected, with elevated expression of 26
inflammatorymarkers, followedby the infrapatellar fat pad (22
up-regulated proteins) and the synovial membrane (10 up-
regulated proteins). These data were used to construct a
Venn diagram (Figure 1B) illustrating the anatomical location
of the up-regulated inflammatory markers. CCL2, CCL3
(MIP-1a), CCL4 (MIP-1b), CCL17 (TARC), CCL22 (MDC),ajp.amjpathol.org - The American Journal of Pathology
Fibroblasts Drive Inflammation and PainIL-8, IP-10, IL-23p40, and tumor necrosis factor-a were up-
regulated in all three regions of the fibrotic joint. By far the
most induced protein was IL-8, which was expressed at
approximately 35-fold, approximately 40-fold, and approxi-
mately 80-fold higher levels in the synovial fluid, infrapatellar
fat pad, and synovial membrane, respectively (Figure 2). The
synovial fluid was the most proinflammatory, with eight
proteins exclusively elevated in revision TKA compared
with primary TKA. These proteins were the granulocyte
recruitment ligands CCL13 (monocyte chemoattractant
protein-4) and CCL26 (eotaxin-3), the granulocyte modulator
granulocyte-macrophage colony-stimulating factor, tumor
necrosis factor-b, the cleaved form of vascular cell adhesion
molecule 1, and proangiogenic factors vascular endothelial
growth factor-C and Fms-like tyrosine kinase 1 (Figure 1B).
Together, these markers suggest the synovial fluid of the
fibrotic joint resembled a state of chronic allergic inflamma-
tion.36 Up-regulated T-cell stimulators IL-2, IL-15, and IL-16,
the inflammatory cytokines IL-1a, IL-1b, and IL-5, and the
cleaved form of intercellular adhesion molecule 1 were com-
mon to the synovialfluid and infrapatellar fat pad of thefibrotic
joint.
Fibroblasts from the Infrapatellar Fat Pad Polarize to a
Proinflammatory Phenotype in Response to IL-1a
Having established that the fibrotic post-TKA joint acquires a
state of unresolved inflammation, it was next determined if fi-
broblasts contribute to this state.Wepreviously reported that the
infrapatellar fat pad is a site at which extensive fibrotic
remodeling and fibroblast accumulation occur after TKA.22
Furthermore, we now demonstrate that fibroblasts in the post-
TKA joint express IL-1R1 (Figure 1A). IL-1a polarizes fibro-
blasts toward a proinflammatory state19 and is elevated in both
the post-TKA infrapatellar fat pad and synovial fluid
(Figure 1B). Fibroblasts isolated from the infrapatellar fat pad
and exposed to pg/mL levels of IL-1a underwent a dramatic
induction of CCL2, IL-6, and IL-8, all being secreted at ng/mL
levels. By contrast, profibrogenic TGF-b1 failed to induce this
proinflammatory state (Figure 3A). IL-6 was remarkable in that
it was a unique inflammatory feature of the infrapatellar fat pad
in the post-TKA joint (Figure 1B). Multiarray protein mea-
surements confirmed that IL-6 is up-regulated in the remodeled
infrapatellar fat pad, but remainsunchanged in the synovialfluid
(Figure 3, B and C). Moreover, elevated IL-1a in the fibrotic
infrapatellar fat pad (pg/mL levels) correlated with enhanced
expressionofCCL2, IL-6, and IL-8 (Figure 3D), suggesting that
fibroblasts exposed to IL-1a in the microenvironment of the
fibrotic infrapatellar fat pad are likely to be a major source of
proinflammatory CCL2, IL-6, and IL-8. In agreement with this,
immunocytochemistry performed on the post-TKA infrapa-
tellar fat pad identified a significant number of the vimentin-
positive fibroblasts that were also positive for IL-6 (Figure 1C).
To determine intracellular signaling pathways responsible
for mediating IL-1aeinduced polarization of fibroblasts, the
cells were treated with inhibitors of downstream signalThe American Journal of Pathology - ajp.amjpathol.orgtransduction molecules. Inhibitors of Janus activating kinase
2, transforming growth factor beactivated kinase 1 (TAK1),
and IKK-2, signaling molecules known to activate the car-
dinal proinflammatory transcription factor NF-kB,37e39
blunted IL-1aeinduced expression of CCL2 by twofold or
greater (Figure 3, E and F, and Supplemental Figure S4).
To investigate the in vivo relevance of these data, a systems
bioinformatics analysis was performed using the protein
expression data derived from the multiarray protein measure-
ments of up-regulated proinflammatory molecules in synovial
fluid of the post-TKA joint (Table 2 and Figure 1B). By using a
network reconstruction technique, the innate immune protein
interactome of the remodeled TKA joint was interrogated
(Figure 4). Of particular note was the mapping of NF-kB
family proteins Rel (c-Rel), RelA (p65), RelB, and NF-kB1
(p50) in a network including CCL17, IP-10, CCL2, CCL22,
CCL3, CCL4, CCL11 (eotaxin), and IL-15, all of which were
identified as up-regulated in one or both of the synovial fluid
and infrapatellar fat pad of the fibrotic post-TKA joint
(Figure 4A). The reconstructed network also contained TAK1,
IKK-2, and the Janus activating kinase 2 target STAT3,
rationalizing their role in the CCL2 response to IL-1a. Proteins
in the network and in highly connected submodules were also
enriched for gene ontology processes, including leukocyte
migration and response to wound healing (Figure 4B).
Inflammatory Fibroblasts Regulate Monocyte
Recruitment via NF-kBeRegulated Expression of CCL2
Having established that IL-1a polarizes fibroblasts toward
an inflammatory phenotype, it was next tested if these cells
are able to directly stimulate recruitment of immune cells,
specifically monocytes. To test this hypothesis, a transwell
migration assay was performed with human THP-1
monocytes and conditioned media from unstimulated,
IL-1aestimulated, or TGF-b1estimulated fibroblasts.
Conditioned media from IL-1aestimulated fibroblasts
significantly increased migration of monocytes compared
with unstimulated cells. TGF-b1 treatment had no effect on
monocyte migration (Figure 5A). Pretreating the condi-
tioned media with neutralizing antibodies against CCL2 and
IL-6 identified CCL2 as the predominant mediator of
monocyte recruitment, such that anti-CCL2 reduced
monocyte recruitment by approximately 80%; in contrast,
antieIL-6 had negligible effects (Figure 5B). Treatment of
IL-1aestimulated fibroblasts with inhibitors of Janus acti-
vating kinase 2, TAK1, and IKK effectively prevented their
ability to recruit monocytes, confirming the requirement of
NF-kB activation (Figure 5C). Because CCL2 was found to
be significantly elevated in the post-TKA synovial fluid and
infrapatellar fat pad and is integrated with NF-kB in the
innate immune interactome of the fibrotic joint, CD68þ
monocytes in the fibrotic joint were quantified. There was a
significant increase in the number of CD68þ monocytes in
the infrapatellar fat pad of fibrotic revision post-TKA joints
compared with nonfibrotic primary TKA joints (Figure 5D).705
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Fibroblasts Drive Inflammation and PainElevated CCL2 in the Inflammatory Environment of the
Fibrotic Post-TKA Joint Correlates with Pain
The degree to which the inflammatory profile of the syno-
vial fluid of the joint stratifies patients into those requiring
revision TKA surgery was quantified. Inflammatory proteins
with the greatest fold change between primary and revision
patients were log transformed and used for hierarchical
clustering, which was visualized by a heat map. The use of
inflammatory protein expression in the synovial fluid was
sufficient to segregate revision from primary TKA patients
with only nZ 1 revision and n Z 2 primary TKA patients
misclassified (Figure 6A). The predictive value of the in-
flammatory profile of the infrapatellar fat pad (Supplemental
Figure S5A) and the synovial membrane (Supplemental
Figure S6A) was also assessed. Although a degree of
stratification was observed with these tissues, there was a
larger degree of overlap between the patient groups
compared with synovial fluid. Principal component analysis
was performed to further investigate the predictive value of
the inflammatory profile in the synovial fluid (Figure 6B).
This approach demonstrated the excellent predictive value
of the synovial fluid, with distinct separation of primary and
revision TKA samples (only n Z 1 revision TKA patient
clustering incorrectly). Similar analysis of the infrapatellar
fat pad (Supplemental Figure S5B) and synovial membrane
(Supplemental Figure S6B) again demonstrated a much
larger degree of overlap compared with synovial fluid. The
R package glmnet was used to select a reduced set of in-
flammatory markers that reliably classify primary and
revision TKA patients. Again, the synovial fluid had the
most predictive value and indicated that a single inflam-
matory marker, CCL2, achieved a misclassification error of
<5% (Figure 6C). Indeed, using CCL2 alone to generate a
receiver operating characteristic curve achieved an area
under the curve of 96.8% (95% CI, 89%e100%) in strati-
fying patients as primary or revision TKA (Figure 6D). The
misclassification error was significantly higher for the
infrapatellar fat pad (Supplemental Figure S5C) and syno-
vial membrane (Supplemental Figure S6C), whereas the
ability of CCL2 alone to stratify patients was also reduced
(infrapatellar fat pad: area under the curve, 84.2%; 95% CI,
74%e95%) (Supplemental Figure S5D) (synovial mem-
brane: area under the curve, 76.9%; 95% CI, 65%e89%)
(Supplemental Figure S6D). For these tissues, glmnetFigure 3 Markers elevated after total knee arthroplasty (TKA) are associated wi
of patients undergoing primary TKA were treated with control media, IL-1a (500 p
secreted levels of CCL2, IL-6, and IL-8, determined by enzyme-linked immunosorb
CCL2, IL-6, and IL-8 protein levels were quantified in synovial fluid (B) and infrap
revision TKA. Data are presented as individual patient values, with median signifie
correlates against CCL2, IL-6, and IL-8 levels in synovial fluid. Data are presented a
F: Fibroblasts isolated from the infrapatellar fat pad of patients undergoing prima
inhibitors [TAK1 inhibitor (TAKi), 1 mmol/L; all other inhibitors, 10 mmol/L] before
by ELISA. Data are analyzed using paired t-tests. Data are presented as means  SE
and ****P < 0.0001 primary versus revision patients. ERK, extracellular signalere
Janus activating kinase; JNK, c-Jun N-terminal kinase; MCP, monocyte chemoatt
The American Journal of Pathology - ajp.amjpathol.organalysis suggested that more complex models containing
additional markers, such as CCL3, CCL13, CCL22, IL-8,
and C-reactive protein, may be better able to stratify pa-
tients, but would still not match the accuracy of CCL2 in
synovial fluid (Supplemental Figures S5C and S6C).
Because degree of pain and stiffness are clinical mea-
sures of success of the post-TKA joint and patient quality
of life,25 the degree to which these clinical outcomes
correlated with inflammatory markers in the joint was
determined. Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) scores for pain and stiff-
ness were obtained from the Newcastle Freeman Joint
Registry for patients consented to this study and correlated
to levels of CCL2 and other markers significantly elevated
in post-TKA patients. A significant correlation between
CCL2 levels in synovial fluid and WOMAC pain scores
was observed, but no correlation with WOMAC stiffness
scores was found (Figure 7). A significant positive corre-
lation was also seen with vascular endothelial growth
factor-C and other markers elevated after TKA, such as
IL-8, CCL22, CCL3, and tumor necrosis factor-a; these
markers also demonstrated a nonstatistically significant
correlation with WOMAC pain scores. Again, there was
little to no correlation between any of the markers and
WOMAC stiffness scores. Interestingly, levels of CCL2,
IL-8, CCL22, and CCL3 in the infrapatellar fat pad were
significantly correlated with WOMAC stiffness scores but
not with WOMAC pain scores (Supplemental Figure S7).
Levels of marker expression did not significantly correlate
with either WOMAC pain or stiffness scores in synovial
membrane (Supplemental Figure S8).
We conclude that inflammatory markers in the post-TKA
synovial fluid correlate with pain and that CCL2, a factor
produced by inflammatory fibroblasts in the fibrotic joint, is
sufficient to predict pain and identify patients requiring
revision TKA surgery.Discussion
Modern lower limb arthroplasty results in pain relief and
satisfactory outcomes in >80% of patients. However, as
many as 20% of patients express post-surgical dissatisfac-
tion because of persistent pain, swelling, loss of movement,
and reduced functional ability in the absence of jointth fibroblast activation. A: Fibroblasts isolated from the infrapatellar fat pad
g/mL), or transforming growth factor (TGF)-b1 (3 ng/mL) for 24 hours and
ent assay (ELISA). Data are analyzed using paired t-tests. B and C: IL-1a,
atellar fat pad (C) and compared between patients undergoing primary and
d by the red line and analyzed using a U-test. D: IL-1a protein expression
s individual patient values with associated linear regression analysis. E and
ry (E) and revision (F) TKA were pretreated for 1 hour with several selective
stimulation with IL-1a (500 pg/mL) for 24 hours, and CCL2 was quantified
M (A, E, and F). nZ 6 (A, E, and F). *P < 0.05, **P < 0.01, ***P < 0.001,
gulated kinase; IKK, Ik B kinase; IRAK, IL-1 receptor associated kinase; JAK,
ractant protein.
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Figure 4 Network and module analysis. A: Protein-protein interaction network built from differentially expressed markers. Red indicates up-regulated
marker protein; green, down-regulated marker protein; blue, proteins with either degree (number of interactions) 5, betweenness centrality 0.01, or
one of a selected set of proteins of interest [transforming growth factor beactivated kinase, IL-1 receptor associated kinase (IRAK) 1, STAT3, Ik B kinase (IKK)
b, or NF-kappa-B essential modulator]. B: Network with one module (highly connected subnetwork) highlighted in purple. Large labeled nodes show proteins
associated with selected enriched gene ontology biological processes mapped to the module; highlighted nodes are associated with the processes positive
regulation of NF-kB transcription factor activity, leukocyte migration, and response to wound healing. CCBP, chemokine-binding protein 2; CEBPB, CCAAT/
enhancer binding protein beta; EGR, early growth response protein 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; HSP, heat shock protein;
MMP, matrix metalloproteinase; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.
Paish et alinstability or infection.25 The epidemiology and etiology of
this postoperative state remain poorly understood, in
particular with respect to pain, yet the symptoms are often
sufficiently severe to necessitate early revision surgery,
within 5 years of the primary operation. The aim of this708study was to determine the nature of the inflammatory
process occurring in joints requiring revision surgery and to
interrogate the potential role of the fibroblast to contribute to
stress-induced inflammatory exacerbations and pain in the
post-TKA knee.ajp.amjpathol.org - The American Journal of Pathology
Figure 5 IL-1aeactivated fibroblasts promote
recruitment of monocytes by secreting CCL2. Fi-
broblasts isolated from the infrapatellar fat pad of
patients undergoing primary total knee arthro-
plasty (TKA) were stimulated with control media,
IL-1a (500 pg/mL), or transforming growth factor
(TGF)-b1 (3 ng/mL) for 24 hours to generate
conditioned media for transwell migration assays.
A: Number of monocytes recruited by conditioned
media from unstimulated (control), IL-1ae
stimulated, and TGF-b1estimulated fibroblasts. B:
Conditioned medium from IL-1aestimulated fi-
broblasts was pretreated for 1 hour with neutral-
izing antibodies against CCL2 and IL-6 and then
used in transwell migration assays. C: Conditioned
medium from fibroblasts pretreated for 1 hour with
several selective inhibitors (transforming growth
factor beactivated kinase, 1 mmol/L; all other
inhibitors, 10 mmol/L) before stimulation with IL-
1a for 24 hours and then used in transwell
migration assays. The number of migrated cells
was quantified on a Nikon Eclipse microscope. Data
are analyzed using paired t-tests. D: Number of
CD68þ cells in the infrapatellar fat pad of patients
undergoing primary and revision TKA was quanti-
fied in 10 randomly selected high-powered fields
using Nikon NIS elements image analysis software.
Data are analyzed using U-test. Data are presented
as means  SEM (C and D). n Z 6 (AeC).
*P < 0.05, **P < 0.01 versus Noi. Original
magnification, 20 (D). ERK, extracellular signal
eregulated kinase; IKK, Ik B kinase; IRAK, IL-1
receptor associated kinase; JAK, Janus activating
kinase; JNK, c-Jun N-terminal kinase.
Fibroblasts Drive Inflammation and PainExtensive fibrotic remodeling is found to be common to
revised TKA joints and is characterized by the accumulation
of fibrotic extracellular matrix into the infrapatellar fat pad
and synovial membrane.22 The fibrotic matrix of the TKA
joint is also characterized by the persistence of high
numbers of a-smooth muscle actine and IL-1R1epositive
fibroblasts.19,35 Herein, we discovered that the fibrotic post-
TKA knee is characterized by a chronic inflammatory
signature and identify IL-1R1epositive fibroblasts as a
potential source of proinflammatory mediators that promote
monocyte recruitment and pain in the TKA joint. This
occurs via a paracrine pathway in which soluble IL-1a
stimulates NF-kBedependent expression of CCL2. This
illuminates a new disease model in which nonresolving
fibrosis becomes a driver of inflammation in response to the
sterile innate immune triggers (IL-1a). This model has
potential relevance to the pathophysiology of all active
fibrotic tissues and may help explain the poorly understood
association of fibrosis with inflammatory flares and chronic
pain in osteoarthritic (OA) joints. We further propose that
targeting the fibroblast in the setting of the fibrotic joint
offers a novel and rationale approach for suppressing
inflammation and pain (ie, worthy of further investigation).The American Journal of Pathology - ajp.amjpathol.orgOur key findings are as follows: i) the synovial fluid and
infrapatellar fat pad of painful TKA joints displayed
elevated expression of multiple inflammatory proteins,
including IL-1a and CCL2; ii) bioinformatics analyses of
soluble protein expression in the inflamed joint indicated
convergence on NF-kB signaling, indicative of a state of
chronic unresolved inflammation; iii) fibroblasts in the
fibrotic infrapatellar fat pad express IL-1R1 and IL-6 in vivo
and in response to IL-1a, polarized toward a highly in-
flammatory phenotype characterized by induction of CCL2
in vitro; and iv) CCL2 levels in the joint closely correlated
with the degree of pain. From a translational perspective, the
main strength of this study is that it identified the association
of IL-1a/NF-kB/CCL2 inflammatory signaling in fibroblasts
as a driver of inflammation and pain using directly relevant
human TKA tissues. Furthermore, this novel pathway offers
multiple points for therapeutic intervention using drugs that
are safe and clinically effective in humans. A limitation of
the study is the limited information available on the revision
patients referred into our unit for specialist treatment. Spe-
cifically, we do not know whether all of the revision patients
had their infrapatellar fat pad excised during their primary
surgery and the extent of the synovial resection initially709
Figure 6 CCL2 in synovial fluid can be used to stratify patients undergoing revision total knee arthroplasty (TKA) from patients undergoing primary TKA. A:
Heat map of log-transformed protein intensity in synovial fluid isolated from patients undergoing primary or revision TKA clustered using the differentially
expressed markers with the highest fold change. Asterisks indicate markers that were used for clustering analysis/stratification. B: Principal component
analysis plot of all patients using all markers. C: Classification error as function of the number of markers included, cross validated using glmnet package.
Dotted lines mark two important values of the regularization parameter l, which controls the number of markers included. On the left is the value of l that
gives the minimum mean cross-validated error. On the right is the value that gives the most regularized model, such that error is within one SEM of the
minimum. D: Receiver operating characteristic curve for classification with CCL2 alone [area under the curve (AUC), 0.968; 95% CI, 0.89e1.0]. CRP, C-reactive
protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM, intercellular adhesion
molecule; IFN, interferon; IP-10, interferon gamma-induced protein 10; PIGF, placental growth factor; SAA, serum amyloid A; Tie, tyrosine kinase; TNF, tumor
necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor.
Paish et alperformed. Fat pad resection has been associated with
increased anterior knee pain and patella baja, which is
suggestive of increased intra-articular scarring.40,41
Traditionally, fibroblasts are considered as structural
cells that, in response to tissue damage, adopt an activated
fibroblast state and promote wound healing and fibro-
genesis via their secretion of fibrous collagens and710inhibitors of collagenases.4 Less well recognized is that
these cells exhibit substantial heterogeneity and pheno-
typic plasticity and can adopt fibroblastic, contractile, or
inflammatory states under the influence of cues in their
microenvironment.13 Polarization of fibroblasts to an in-
flammatory state is characterized by their acquired
expression of IL-6 and IL-8. Studies in fibroblasts derivedajp.amjpathol.org - The American Journal of Pathology
Figure 7 Pain positively correlates with levels of CCL2 in synovial fluid. Pain and stiffness, as determined by Western Ontario and McMaster Universities
Osteoarthritis Index scores, were plotted against expression levels of several markers that were significantly elevated in the synovial fluid of patients un-
dergoing revision total knee arthroplasty (TKA). Data are presented for patients undergoing primary and revision TKA, and correlations were determined by
linear regression analysis. Increased levels of CCL2 are highly predictive of pain but are poorly correlated to stiffness. n Z 13 primary TKA group; n Z 18
revision TKA group. TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.
Fibroblasts Drive Inflammation and Painfrom multiple tissues (eg, lung, intestine, heart, and skin)
indicate that the innate immune trigger IL-1a is a powerful
paracrine stimulator of an inflammatory polarization of
their phenotype.12,14,15,17,42 It was found to be true for fi-
broblasts derived from the infrapatellar fat pad, such that
exposure to pg/mL levels of IL-1a induced ng/mL levels of
secreted IL-6, IL-8, and CCL2. More important, IL-1R1
and IL-6 expression was located primarily to fibroblasts
in the fibrotic infrapatellar fat pad, whereas soluble IL-1a,
IL-6, IL-8, and CCL2 were also elevated and correlated
with IL-1a levels in the infrapatellar fat pad of the TKA
joint. An important future question will be to identify the
cellular source of IL-1a in the joint because this infor-
mation will reveal the underlying cellular damage/stressThe American Journal of Pathology - ajp.amjpathol.orgmechanisms that trigger the activation of inflammatory fi-
broblasts of fibrotic tissue. Potential resident sources of IL-
1a in the knee include macrophage-like type A and
fibroblast-like type B synovial cells.43,44
Fibroblasts persisting in the fibrotic TKA joint express
IL-1R1, indicating they are primed for polarization to an
inflammatory state on exposure to IL-1a. Scarpa et al42
reported that fibroblasts isolated from inflammatory
bowel disease tissue expressed IL-1R1, as did intestinal
subepithelial fibroblasts in the intestine of mice challenged
with a low dose of dextran sulfate sodium. More important,
after mice had recovered from this mild intestinal injury, a
subsequent intrarectal administration of IL-1a induced
severe colitis, whereas mice that had not undergone prior711
Paish et aldextran sulfate sodiumeinduced tissue remodeling failed
to mount an inflammatory response to IL-1a. The
appearance of IL-1R1epositive fibroblasts, therefore,
appears to constitute a tissue memory of previous damage
that primes the tissue for a robust inflammatory flare when
these cells engage IL-1a in the microenvironment. This
concept challenges the traditional simple linear model of
fibrogenesis in which inflammation is the driver of fibrosis.
Instead, we propose a dynamic positive feed-forward
process in which inflammatory fibroblasts sense local
tissue damage and, via release of CCL2 and other che-
mokines, promote the recruitment and activation of innate
immune cells to drive inflammation; this process consti-
tutes a circulus vitiosus.
CCL2 classically operates as a chemoattractant for
monocytes by binding to its receptor CCR2.45,46 CCL2 is
highly expressed in the synovial fluid of OA joints and
knees after trauma and, as observed herein, is a feature of
the inflammatory synovium and infrapatellar fat pad of the
fibrotic TKA joint.47e50 Although no data directly demon-
strating that CCL2 is driving the recruitment of monocytes
in vivo have been presented, we hypothesize that the
elevated levels of CCL2 in the post-TKA knee are likely one
of the factors contributing to the recruitment of CD68þ cells
in a similar manner to what has recently been reported in
OA.51 An unexpected and novel finding was the close
correlation between levels of CCL2 in the synovial fluid of
the TKA joint and reported WOMAC pain scores, although
no correlation was observed between levels of CCL2 in
infrapatellar fat pad and synovial membrane and reported
WOMAC pain scores. Although the synovial fluid is un-
likely to contain significant numbers of fibroblasts, it is
highly likely that fibroblasts present within joint tissues
(including the infrapatellar fat pad and synovial membrane
as well as other intra-articular or periarticular tissues, such
as the joint capsule) are contributing to chronic inflamma-
tion in the synovial fluid, as has been previously reported in
OA.52 In this context, it is intriguing that sensory neurons
express CCR2 and, furthermore, CCL2-CCR2 engagement
leads to excitation of nociceptive neurons, an event usually
associated with the sensation of pain.53e56 In a murine
model of OA, genetic deletion of either CCL2 or CCR2
delayed the onset of pain-related behavior.57 These obser-
vations warrant future studies examining the potential for
the use of emerging small-molecule inhibitors of CCR2 as
therapies for relieving inflammation and intractable pain in
the OA and/or post-TKA joint. Alternatively, a similar
outcome may be achieved by the local administration of the
IL-1R1 antagonist, anakinra; indeed, there is prior clinical
evidence that this approach may be beneficial in TKA.58
Because NF-kB signaling appears to be pivotal for IL-
1aeinduced expression of CCL2 by fibroblasts, there may
also be an analgesic benefit to be gained from the local
administration of small-molecule inhibitors of NF-kB or its
upstream kinase, IKK.59,60 Such an approach may also
reduce numbers of fibroblasts in the fibrotic tissue because712suppression of NF-kB in these cells is associated with the
induction of apoptosis.61
In summary, this study identified an important role for
fibrosis-associated fibroblasts as sensors of cellular stress/
damage via engagement of surface-expressed IL-1R1 with the
alarmin IL-1a, which leads to secretion of CCL2, a well-
established stimulator of monocyte recruitment and nocicep-
tive pain. We hypothesize that IL-1R1eexpressing fibroblasts
persist in unresolved fibrotic tissue and prime the tissue for
inflammatory episodes in response to local cell stress/damage.
Finally, the inflamed post-TKA joint is an important new
human disease model with which to further illuminate the
complex cross talk between fibrosis, inflammation, and pain.
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